Chandan Healthcare Limited used Rs 36.52 crore by September 2026
Key highlights
- Chandan Healthcare had used Rs 36.52 crore of preferential-issue proceeds by September 30, 2026.
- Rs 56.16 crore remained payable upon warrant conversion by July 28, 2027.
- Business expansion accounted for Rs 31.76 crore of utilisation at September 30, 2026.
- Chandan Healthcare held Rs 11.45 crore of unutilised proceeds in deposits and an ICICI Bank account.
powered by IRIS

Chandan Healthcare Limited had used Rs 36.52 crore of preferential-issue proceeds by September 30, 2026, while Rs 56.16 crore of the Rs 104.13 crore issue remained payable only if warrants were converted by July 28, 2027. Rs 11.45 crore of received, unutilised funds was held in deposits and a bank account.
Know Chandan Healthcare inside out
Results, valuation, peers and who's buying, in one view.
How much of Chandan Healthcare's preferential issue had been received and used?
Chandan Healthcare had used Rs 36.52 crore at September 30, 2026, and retained Rs 11.45 crore as unutilised proceeds, together representing Rs 47.97 crore reflected in its utilisation schedule. The balance of Rs 56.16 crore from the Rs 104.13 crore preferential issue was yet to be received and was payable by warrant holders only on conversion.
The amount used rose by Rs 8.39 crore during the quarter ended September 30, 2026, from Rs 28.13 crore at the beginning of the period to Rs 36.52 crore at its close. The filing states that the Rs 8.39 crore moved during the quarter was transferred to the company's current accounts for business-expansion use and was fully utilised by quarter end.
The Rs 47.97 crore represented by utilised and unutilised funds is lower than the full issue size because the warrant holders had not yet paid the Rs 56.16 crore conversion amount as at September 30, 2026. The filing does not describe that unpaid amount as cash held by Chandan Healthcare at the reporting date.
Where did Chandan Healthcare use the received proceeds?
Chandan Healthcare reported Rs 31.76 crore of utilisation for business expansion and Rs 4.76 crore for general corporate purpose, or GCP, at September 30, 2026. It reported no utilisation for acquisitions, although acquisitions carried the largest offer-document allocation of Rs 50.00 crore.
Business-expansion utilisation increased from Rs 23.38 crore at the beginning of the July-September 2026 quarter to Rs 31.76 crore at its end. The offer document allocated Rs 44.50 crore to that object, and the filing says business expansion also includes settlement of outstanding dues payable to various vendors.
GCP utilisation was unchanged at Rs 4.76 crore between the beginning and end of the reported quarter, with no spending recorded in July-September 2026. Acquisitions likewise remained at zero utilisation through the quarter, while the table recorded no unutilised received proceeds against that object.
Where was Chandan Healthcare's Rs 11.45 crore unutilised balance held?
Chandan Healthcare held its Rs 11.45 crore unutilised balance in fixed deposits and a bank account at September 30, 2026. Rs 11.44 crore was held in the monitoring-agency account with ICICI Bank, while Rs 1.36 lakh was invested in fixed deposits.
The fixed deposit had a disclosed return on investment of 6.5% per annum and a stated quarter-end value of Rs 1.36 lakh. The filing did not disclose a maturity date for that deposit, and it did not state a return on the Rs 11.44 crore bank balance.
The entire Rs 11.45 crore unutilised balance was reported against business expansion, compared with nil balances for acquisitions and GCP. The company stated that the balance was invested in fixed deposits, with the remaining amount held as a bank balance in the preferential-issue account.
Got a follow-up? Ask IRIS
When can Chandan Healthcare receive the remaining Rs 56.16 crore?
Chandan Healthcare can receive the remaining Rs 56.16 crore if warrant holders convert their share warrants into equity shares by July 28, 2027. The filing says the amount is payable on conversion within 18 months from the warrant-allotment date, as set out in the notice to shareholders.
That conversion condition separates the Rs 56.16 crore from the Rs 47.97 crore recorded as utilised or unutilised in the September 30, 2026 schedule. The filing reported no change in the means of finance for the disclosed objects and no major deviation from earlier monitoring-agency reports.
Chandan Healthcare also reported that utilisation was in line with the offer-document disclosures, with no deviation from the objects stated in the September-quarter report. Its implementation-delay table marked the completion-date and delay fields as not applicable.
What did the auditor say about Chandan Healthcare's fund use?
MSNT & Associates LLP said on October 23, 2026 that nothing had come to its attention suggesting the use of preferential-issue proceeds during July 1 to September 30, 2026 was inconsistent with Chandan Healthcare's unaudited books or the purposes in the notice to shareholders. The certificate was issued for submission to the monitoring agency.
The auditor described its work as a limited-assurance examination, not an audit or review conducted under generally accepted auditing standards in India. Its procedures included tracing proceeds from bank statements, checking supporting records, and verifying current-account and fixed-deposit closing balances using bank confirmations supplied by management.
The certificate covered the quarter ended September 30, 2026 and was based on the company's unaudited books for July 1 to September 30, 2026. The auditor stated that the assurance obtained was substantially lower than the assurance available from a reasonable-assurance engagement.
Conclusion
Chandan Healthcare had deployed Rs 36.52 crore of the proceeds reflected in its September 30, 2026 utilisation schedule, comprising Rs 31.76 crore for business expansion and Rs 4.76 crore for GCP. A further Rs 11.45 crore remained identifiable in a fixed deposit and an ICICI Bank monitoring-agency account, while acquisitions had no reported utilisation.
The next disclosed milestone is July 28, 2027, when the 18-month warrant-conversion period ends for the Rs 56.16 crore still payable by warrant holders. The key reported matters to watch are whether those proceeds are received, whether the Rs 11.45 crore business-expansion balance is deployed, and whether acquisition spending begins.


